{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:49:58Z","timestamp":1774007398821,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Sciences","doi-asserted-by":"crossref","award":["26293033"],"award-info":[{"award-number":["26293033"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Sciences","doi-asserted-by":"crossref","award":["15K08074"],"award-info":[{"award-number":["15K08074"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00408-016-9935-7","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T17:50:56Z","timestamp":1473270656000},"page":"923-930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Methotrexate-Induced Epithelial\u2013Mesenchymal Transition in the Alveolar Epithelial Cell Line A549"],"prefix":"10.1007","volume":"194","author":[{"given":"Masashi","family":"Kawami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Harabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mioka","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risako","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Yumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihisa","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"9935_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1535-7163.MCT-06-0343","volume":"6","author":"S Chattopadhyay","year":"2007","unstructured":"Chattopadhyay S, Moran RG, Goldman ID (2007) Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications. Mol Cancer Ther 6:404\u2013417","journal-title":"Mol Cancer Ther"},{"key":"9935_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.57.2.3","volume":"57","author":"BN Cronstein","year":"2006","unstructured":"Cronstein BN (2006) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57:163\u2013172","journal-title":"Pharmacol Rev"},{"key":"9935_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00148581-200608060-00003","volume":"8","author":"T Niehues","year":"2006","unstructured":"Niehues T, Lankisch P (2006) Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Paediatr Drugs 8:347\u2013356","journal-title":"Paediatr Drugs"},{"key":"9935_CR4","unstructured":"Calvo I, Anton J, Lopez Robledillo JC et al. (2015) Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis. An Pediatr (Barc)"},{"key":"9935_CR5","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1073\/pnas.0605669103","volume":"103","author":"KK Kim","year":"2006","unstructured":"Kim KK, Kugler MC, Wolters PJ et al (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180\u201313185","journal-title":"Proc Natl Acad Sci USA"},{"key":"9935_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890","journal-title":"Cell"},{"key":"9935_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9935_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","volume":"40","author":"A Moeller","year":"2008","unstructured":"Moeller A, Ask K, Warburton D et al (2008) The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40:362\u2013382","journal-title":"Int J Biochem Cell Biol"},{"key":"9935_CR9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn TA (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208:1339\u20131350","journal-title":"J Exp Med"},{"key":"9935_CR10","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez DM, Medici D (2014) Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 7:re8","journal-title":"Sci Signal"},{"key":"9935_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massague","year":"1998","unstructured":"Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753\u2013791","journal-title":"Annu Rev Biochem"},{"key":"9935_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00232-014-9643-2","volume":"247","author":"Q Mei","year":"2014","unstructured":"Mei Q, Saiz L (2014) Literature-based automated reconstruction, expansion, and refinement of the TGF-beta superfamily ligand-receptor network. J Membr Biol 247:381\u2013386","journal-title":"J Membr Biol"},{"key":"9935_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J (2008) TGFbeta in Cancer. Cell 134:215\u2013230","journal-title":"Cell"},{"key":"9935_CR14","unstructured":"Attisano L, Lee-Hoeflich ST (2001) The Smads. Genome Biol 2: Reviews 3010"},{"key":"9935_CR15","doi-asserted-by":"publisher","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","volume":"293","author":"BC Willis","year":"2007","unstructured":"Willis BC, Borok Z (2007) TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293:L525\u2013L534","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9935_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.taap.2015.01.004","volume":"283","author":"LJ Chen","year":"2015","unstructured":"Chen LJ, Ye H, Zhang Q et al (2015) Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells. Toxicol Appl Pharmacol 283:75\u201382","journal-title":"Toxicol Appl Pharmacol"},{"key":"9935_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2131\/jts.39.319","volume":"39","author":"M Ohbayashi","year":"2014","unstructured":"Ohbayashi M, Kubota S, Kawase A et al (2014) Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis. J Toxicol Sci 39:319\u2013330","journal-title":"J Toxicol Sci"},{"key":"9935_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dmpk.2014.10.007","volume":"30","author":"M Takano","year":"2015","unstructured":"Takano M, Yamamoto C, Yamaguchi K et al (2015) Analysis of TGF-beta1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE\/Abca3. Drug Metab Pharmacokinet 30:111\u2013118","journal-title":"Drug Metab Pharmacokinet"},{"key":"9935_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1465-9921-6-56","volume":"6","author":"H Kasai","year":"2005","unstructured":"Kasai H, Allen JT, Mason RM et al (2005) TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 6:56","journal-title":"Respir Res"},{"key":"9935_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3346\/jkms.2007.22.5.898","volume":"22","author":"JH Kim","year":"2007","unstructured":"Kim JH, Jang YS, Eom KS et al (2007) Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells. J Korean Med Sci 22:898\u2013904","journal-title":"J Korean Med Sci"},{"key":"9935_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.dmpk.2015.04.005","volume":"30","author":"M Kawami","year":"2015","unstructured":"Kawami M, Miyamoto M, Yumoto R et al (2015) Methotrexate influx via folate transporters into alveolar epithelial cell line A549. Drug Metab Pharmacokinet 30:276\u2013281","journal-title":"Drug Metab Pharmacokinet"},{"key":"9935_CR22","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/art.1780391203","volume":"39","author":"BN Cronstein","year":"1996","unstructured":"Cronstein BN (1996) Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 39:1951\u20131960","journal-title":"Arthritis Rheum"},{"key":"9935_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1164\/ajrccm.155.2.9032171","volume":"155","author":"JP Lynch 3rd","year":"1997","unstructured":"Lynch JP 3rd, McCune WJ (1997) Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 155:395\u2013420","journal-title":"Am J Respir Crit Care Med"},{"key":"9935_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0049-0172(98)80049-8","volume":"27","author":"AE van Ede","year":"1998","unstructured":"van Ede AE, Laan RF, Blom HJ et al (1998) Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum 27:277\u2013292","journal-title":"Semin Arthritis Rheum"},{"key":"9935_CR25","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776\u20131784","journal-title":"J Clin Invest"},{"key":"9935_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI0215518","volume":"110","author":"M Iwano","year":"2002","unstructured":"Iwano M, Plieth D, Danoff TM et al (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341\u2013350","journal-title":"J Clin Invest"},{"key":"9935_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1164\/rccm.200405-612OC","volume":"171","author":"P Bonniaud","year":"2005","unstructured":"Bonniaud P, Margetts PJ, Kolb M et al (2005) Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171:889\u2013898","journal-title":"Am J Respir Crit Care Med"},{"key":"9935_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexmp.2006.12.003","volume":"83","author":"H Higashiyama","year":"2007","unstructured":"Higashiyama H, Yoshimoto D, Kaise T et al (2007) Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 83:39\u201346","journal-title":"Exp Mol Pathol"},{"key":"9935_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/mol.62.1.65","volume":"62","author":"GJ Inman","year":"2002","unstructured":"Inman GJ, Nicolas FJ, Callahan JF et al (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62:65\u201374","journal-title":"Mol Pharmacol"},{"key":"9935_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/01902140303768","volume":"29","author":"S Koyama","year":"2003","unstructured":"Koyama S, Sato E, Takamizawa A et al (2003) Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. Exp Lung Res 29:91\u2013111","journal-title":"Exp Lung Res"},{"key":"9935_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tox.2008.11.016","volume":"256","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Song M, Ryu JC (2009) Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicol 256:183\u2013190","journal-title":"Toxicol"},{"key":"9935_CR32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9282","author":"D Wu","year":"2016","unstructured":"Wu D, Cheng J, Sun G et al (2016) p70S6\u00a0K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma. Oncotarget. doi:\n                    10.18632\/oncotarget.9282","journal-title":"Oncotarget"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-016-9935-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-016-9935-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T06:23:03Z","timestamp":1589696583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-016-9935-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9935"],"URL":"https:\/\/doi.org\/10.1007\/s00408-016-9935-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]},"assertion":[{"value":"30 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement"}}]}}